Clinical Chemistry Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 45: 897-898, 1999;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (21)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Biondi, M. L.
Right arrow Articles by Guagnellini, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Biondi, M. L.
Right arrow Articles by Guagnellini, E.
Related Collections
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 1999;45:897-898.)
© 1999 American Association for Clinical Chemistry, Inc.


Technical Briefs

Contribution of the TATA-Box Genotype (Gilbert Syndrome) to Serum Bilirubin Concentrations in the Italian Population

Maria Luisa Biondi1,a, Olivia Turri1, Dario Dilillo2, Giorgio Stival2 and Emma Guagnellini1

1 Laboratorio di Chimica Clinica e Microbiologia, Azienda Ospedaliera San Paolo, Via di Rudinì 8, 20142 Milan, Italy;
2 Clinica Pediatrica, Azienda Ospedaliera San Paolo, Università di Milano, Via di Rudinì 8, 20142 Milan, Italy;
a author for correspondence: fax 39-0289128221

Gilbert syndrome, a benign unconjugated hyperbilirubinemia without structural liver disease or overt hemolysis, is characterized by episodes of mild intermittent jaundice (1)(2)(3). Gilbert syndrome is the most common inherited variant of hepatic bilirubin metabolism, occurring in 2–12% of the population, and it is often detected in adulthood during routine blood tests. The most consistent feature in Gilbert syndrome is a deficiency in bilirubin glucuronidation, but the metabolism of drugs may also be affected(3).

Recently, the molecular basis of Gilbert syndrome was elucidated and found to result from molecular lesions in one of the isoforms of the UDP-glucuronosyl transferase (UGT-1A) gene. UGT-1A is encoded by the UDG gene complex, which is composed of multiple unique forms of exon 1, each one specific for a single isoenzymes, and four common exons (from two to five) (4). UGT-1A is responsible for bilirubin glucuronidation; the other isoenzymes of the complex are involved in the metabolism of a number of aromatic compounds(5).

The most common genetic alteration of UGT-1A is a TA insertion in the repetitive TATA-box . . . [Full Text of this Article]


References




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
E. Costa, E. Vieira, and R. dos Santos
The Polymorphism c.-3279T>G in the Phenobarbital-Responsive Enhancer Module of the Bilirubin UDP-Glucuronosyltransferase Gene Is Associated with Gilbert Syndrome
Clin. Chem., November 1, 2005; 51(11): 2204 - 2206.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. D. Zucker, X. Qin, S. D. Rouster, F. Yu, R. M. Green, P. Keshavan, J. Feinberg, and K. E. Sherman
Mechanism of indinavir-induced hyperbilirubinemia
PNAS, October 12, 2001; (2001) 231140698.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. Guillemette, I. De Vivo, S. E. Hankinson, C. A. Haiman, D. Spiegelman, D. E. Housman, and D. J. Hunter
Association of Genetic Polymorphisms in UGT1A1 with Breast Cancer and Plasma Hormone Levels
Cancer Epidemiol. Biomarkers Prev., June 1, 2001; 10(6): 711 - 714.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. D. Zucker, X. Qin, S. D. Rouster, F. Yu, R. M. Green, P. Keshavan, J. Feinberg, and K. E. Sherman
Mechanism of indinavir-induced hyperbilirubinemia
PNAS, October 23, 2001; 98(22): 12671 - 12676.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Association for Clinical Chemistry.